5 minute read
Nov. 28, 2022

BI-0474: A Covalent KRAS(G12C) Inhibitor from a Reversible Fragment

BI-0474

IP KRASG12Ci related to oral candidate BI 1823911 TGI in NCI-H358 cancer xenograft mouse model from 13k cmpd. HSQC-based screen and SBDD J. Med. Chem. Boehringer Ingelheim, Vienna, AT

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in